Triple
T23399721
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ELN |
E559469
|
entity |
| Predicate | associatedCompany |
P629
|
FINISHED |
| Object | Elan Pharmaceuticals |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Elan Pharmaceuticals | Statement: [ELN, associatedCompany, Elan Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Elan Pharmaceuticals Context triple: [ELN, associatedCompany, Elan Pharmaceuticals]
-
A.
Elan Pharmaceuticals
chosen
Elan Pharmaceuticals was a biotechnology company best known for developing therapies for neurological and autoimmune diseases, including the multiple sclerosis drug Tysabri.
-
B.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
C.
Gland Pharma
Gland Pharma is an Indian pharmaceutical company specializing in injectable formulations and contract manufacturing for global markets.
-
D.
United Therapeutics
United Therapeutics is a biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other serious cardiopulmonary conditions.
-
E.
Idun Pharmaceuticals
Idun Pharmaceuticals is a biotechnology company focused on developing therapies that regulate cell death pathways, particularly apoptosis, for the treatment of various diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24549610c8190a069d6411ce5f661 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1a4dedfcc8190ab93cec3c3d15c53 |
completed | April 29, 2026, 6:27 a.m. |
Created at: April 17, 2026, 5:37 p.m.